Surgical revascularization for Moyamoya disease in the United States: A cost-effectiveness analysis
Arvin R. Wali, David. R. Santiago-Dieppa, Shanmukha Srinivas, Michael G. Brandel, Jeffrey A. Steinberg, Robert C Rennert, Ross Mandeville, James D. Murphy, Scott Olson, J. Scott Pannell, Alexander A. Khalessi
J Cerebrovasc Endovasc Neurosurg. 2021;23(1):6-15.   Published online 2021 Feb 5     DOI:
Citations to this article as recorded by Crossref logo
Referral of Pediatric Moyamoya for Revascularization: Financial and Quality Data Supporting Private Insurer Approval for Out‐of‐Network Care
Shivani D. Rangwala, Nikita Singh, Jennifer Judge, Christopher Isibor, Craig D. McClain, Laura L. Lehman, Alfred P. See, Darren B. Orbach, Edward R. Smith
Stroke: Vascular and Interventional Neurology.2024;[Epub]     CrossRef
Revascularization of Hemorrhagic Moyamoya Disease in a North American Cohort: The Role of Timing in Perioperative and Long-Term Outcomes
Risheng Xu, Michael E. Xie, James Feghali, Wuyang Yang, Jennifer Kim, Ryan Lee, Jason Liew, Rafael J. Tamargo, Judy Huang
Neurosurgery.2022; 90(4): 434.     CrossRef
Angiographic Characteristics of Cerebral Perfusion and Hemodynamics of the Bridging Artery After Surgical Treatment of Unilateral Moyamoya Disease
Kun Zhang, Wei Ren, Yu-Xue Sun, Xin-Jun Wang, Chao-Yue Li, Zi-Liang Wang, Tian-Xiao Li, Bu-Lang Gao
Frontiers in Neuroscience.2022;[Epub]     CrossRef